Germany is the bigger Epilepsy Drugs market: $351 Mn against $250 Mn in 2023, about 1.4 times as large.
Germany grows faster: 1.7% a year, against 1.5%.
Clinical research: 35 active trials in the UK, 23 in Germany.
| Measure |  UK |  Germany |
|---|---|---|
| Market size, 2023 | $250 Mn | $351 Mn |
| Market size, 2033 projected | $290 Mn | $416 Mn |
| Growth a year (CAGR) | 1.5% | 1.7% |
| Money added, 2023–2033 | $40 Mn | $65 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $3.59 | $4.21 |
| Active clinical trials | 35 | 23 |
| Full report | UK report | Germany report |
Year by year, 2023 to 2033
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Epilepsy Drugs, UK or Germany?
Germany is the bigger Epilepsy Drugs market: $351 Mn against $250 Mn in 2023, about 1.4 times as large.
Which grows faster in Epilepsy Drugs, UK or Germany?
Germany grows faster: 1.7% a year, against 1.5%.
More Epilepsy Drugs comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.